Hello, Fool! | Login | Signup | My Fool
Sep 7, 2008 3:24 AM ET | Site Changes | Help
The Company's Biopharmaceuticals unit is engaged in research, development and commercial activities and its EDT unit focuses on product development, scale-up and manufacturing to address drug optimization challenges of the pharmaceutical industry.
View All Commentary (ELN)
Recs
bermudatrader (90.29) Submitted: 1/26/08 4:18 PM : Start Price: $22.42 ELN Score: -35.56
Solid alzheimers pipeline and the best MS drug on the market.Phase II results for AAb-001 come out this spring/summer, good data will propel this stock to the $40's.
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.